2014
DOI: 10.1021/jo501101s
|View full text |Cite
|
Sign up to set email alerts
|

On Guanidinium and Cellular Uptake

Abstract: Guanidinium-rich scaffolds facilitate cellular translocation and delivery of bioactive cargos through biological barriers. Although impressive uptake has been demonstrated for nonoligomeric and nonpept(o)idic guanidinylated scaffolds in cell cultures and animal models, the fundamental understanding of these processes is lacking. Charge pairing and hydrogen bonding with cell surface counterparts have been proposed, but their exact role remains putative. The impact of the number and spatial relationships of the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
75
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 77 publications
(78 citation statements)
references
References 82 publications
3
75
0
Order By: Relevance
“…[ 1 ] The same principle has been widely applied to enhance the internalization of cell‐penetrating peptides (CPPs), for example, by the incorporation of hydrophobic residues such as phenylalanine or tyrosine. [ 2,3 ] Ever since the first report of gene therapy by Merril et al in 1971, one of the pressing challenges we still face is the invention of an efficient non‐viral delivery vector that can transport genetic materials inside living cells. [ 4 ] The design of such synthetic vectors is often inspired by nature and it is frequently based on cationic macromolecules with well‐defined molecular weight, dispersity, and functionality.…”
Section: Polymer Samples Experimental [Mol%] Mnexperimental [G Mol–1]mentioning
confidence: 99%
“…[ 1 ] The same principle has been widely applied to enhance the internalization of cell‐penetrating peptides (CPPs), for example, by the incorporation of hydrophobic residues such as phenylalanine or tyrosine. [ 2,3 ] Ever since the first report of gene therapy by Merril et al in 1971, one of the pressing challenges we still face is the invention of an efficient non‐viral delivery vector that can transport genetic materials inside living cells. [ 4 ] The design of such synthetic vectors is often inspired by nature and it is frequently based on cationic macromolecules with well‐defined molecular weight, dispersity, and functionality.…”
Section: Polymer Samples Experimental [Mol%] Mnexperimental [G Mol–1]mentioning
confidence: 99%
“…Although other guanidinium-rich transporters [18][19][20][21][22][23] have been used to improve the intracellular delivery of liposomes, [24][25][26][27][28][29][30][31] GNeo is unique in being a highly lysosomotropic transporter capable of delivery through heparan sulfate exclusive pathways. 15 In addition to the universal benefits of liposomal packaging, incorporation of GNeo significantly increases the uptake and lysosomal delivery of diverse cargo compared to unmodified liposomes.…”
Section: -17mentioning
confidence: 99%
“…Another major reason to include guanidinium into a drug might be its potential role in facilitating cellular uptake. 58 Therefore, the guanidine derivatives have great potential to be promising novel drugs. Phe and Trp as well as Leu, Lys and Met tend to occur within 10 Å of Arg-Arg pairings.…”
Section: Acs Paragon Plus Environmentmentioning
confidence: 99%